Linked Life Data

7883752

Source:http://linkedlifedata.com/resource/pubmed/id/7883752

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1995-4-10
pubmed:abstractText
A trypsin inhibitor from hemolymph of the solitary ascidian, Halocynthia roretzi, has been reported to be present in two forms, ATI-I and ATI-II. ATI-I consists of a single polypeptide chain with a unique sequence of 55 amino acid residues, while ATI-II has two chains that seem to be derived from ATI-I by cleavage at the Lys16-Met17 bond [Kumazaki, T., Hoshiba, N., Yokosawa, H., and Ishii, S. (1990) J. Biochem. 107, 409-413]. ATI-II (as modified inhibitor) was proved to be produced by incubation of ATI-I (as virgin inhibitor) with a catalytic amount of bovine trypsin. The tryptic hydrolysis at the Lys16-Met17 bond in virgin inhibitor showed a maximum velocity at around pH 3.5. On the other hand, acid treatment of a complex prepared by mixing equimolar quantities of trypsin and the the modified inhibitor yielded free trypsin and the virgin inhibitor. The results of chemical analyses indicated that the Lys16-Met17 bond that had been cleaved in ATI-II was resynthesized by the acid treatment. These findings strongly suggest that the Lys16-Met17 bond is the reactive site of ATI for trypsin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0021-924X
pubmed:author
pubmed:issnType
Print
pubmed:volume
116
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
787-93
pubmed:dateRevised
2007-12-19
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Identification of the reactive site of ascidian trypsin inhibitor.
pubmed:affiliation
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo.
pubmed:publicationType
Journal Article, Comparative Study